This report mainly covers Circulating Tumor Cells products, by types (CTC enrichment, CTC detection and CTC analysis), by applications (Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others).

Published by: GIR (GlobalInfoResearch)
Catalog: Pharma & Healthcare
Publishing Date: Dec 2016
Single User License: USD 3480
Corporate Users License: USD 4680
Delivery time: 24 hours
Pages: 110
Tables and Figures: 133

Full information ：[url]http://www.globalinforesearch.com/goods.php?id=2624[url]

Scope of the Report:

This report focuses on the Circulating Tumor Cells in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Roche
Thermo Fisher Scientific
Illumina
Agilent Technologies
Laboratory Corporation
Promega
GE Healthcare
QIAGEN
LGC Forensics
Morpho (Safran)
NEC
ZyGEM
Applied DNA Sciences Inc

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
CTC enrichment
CTC detection
CTC analysis

Market Segment by Applications, can be divided into
Prostate Cancer
Breast Cancer
Colorectal Cancer
Others

There are 13 Chapters to deeply display the global Circulating Tumor Cells market.

Chapter 1, to describe Circulating Tumor Cells Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Circulating Tumor Cells, with sales, revenue, and price of Circulating Tumor Cells, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Circulating Tumor Cells, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Circulating Tumor Cells market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Circulating Tumor Cells sales channel, distributors, traders, dealers, appendix and data source.

Betty
Sales Director
E-mail：[email protected]
Tel: HK:00852-58197708 USA:0013479661888
Add: Room 1902 Two International Finance Centre 8 Finance Street, Central Hong Kong
Website: http://www.globalinforesearch.com/goods_all.php